<DOC>
	<DOCNO>NCT01107574</DOCNO>
	<brief_summary>This study assess benefit intervention gabapentin , Osteopathic Manipulative Medicine improvement symptom Fibromyalgia . This study also seek determine whether treatment decrease number severity tender point , improve structure , function overall pain level patient baseline study end . This study design evaluate whether subject subjectively experience improve quality life increase function result intervention correspond objective improvement .</brief_summary>
	<brief_title>Fibromyalgia Treatment Trial With Gabapentin Osteopathic Manipulative Medicine</brief_title>
	<detailed_description>An 8-week , randomize , study design compare gabapentin ( 900 mg/day ) ( n = 8 patient ) OMM ( n = 11 patient ) Combined treatment gabapentin ( 900 mg/day ) plus OMM ( n = 7 patient ) efficacy safety treat pain , fatigue , depression function associate fibromyalgia . The primary outcome measure measure week 2 week 8 evaluate efficacy arm compare efficacy arm improving structure , function pain . The Baker Wong Brief Pain Inventory ( BPI ) evaluate weekly average pain severity score ( range 0-10 , 0 = pain 10 = pain bad imagine ) . Fibromyalgia Impact Questionnaire ( FIQ ) tool evaluate function health status administer week 2 week 8 comparison function baseline end study . The total number Tender Points ( 0-18 ) determine American College Rheumatology count week 2 week 8 compare number tender point baseline end . Dolorimetry Kg/cm2 measure Fischer Dolorimeter measure 4 severe tender point week 2 week 8 compare severity tender point baseline end study . The Osteopathic Structural Examination measure free range motion joint degree measure goniometry week 2 week 8 evaluate degree free range motion improve baseline . The Clinical Global Impression likert scale 1-5 ask patient evaluate feel overall health take week 2 week 8 see overall subjective thought health improve baseline .</detailed_description>
	<mesh_term>Fibromyalgia</mesh_term>
	<mesh_term>Myofascial Pain Syndromes</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>Female male patient eligible study 1865 year age meet ACR criterion fibromyalgia ( [ 1 ] ) . Patients rheumatic medical disorder contribute symptom fibromyalgia exclude . Rheumatoid arthritis , inflammatory arthritis , autoimmune disease ; Pain traumatic injury structural regional rheumatic disease ; Rheumatoid arthritis , inflammatory arthritis , autoimmune disease ; Unstable medical psychiatric illness ; Lifetime history psychosis , hypomania mania , epilepsy , dementia ; Substance abuse last 6 month ; Serious risk suicide ; Pregnancy breastfeeding ; Unacceptable contraception childbearing potential ; Patients , opinion investigator , treatment refractory ; prior fail treatment gabapentin , pregabalin OMM .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Chronic Pain , tenderpoints , insomnia , mood disorder , fatigue</keyword>
</DOC>